Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Dezember 2025 08:00 ET | Quelle: Ovid Therapeutics Inc.

Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral direct activator, OV4071There were no treatment-related laboratory findings, no...
17. Dezember 2025 08:31 ET | Quelle: Moleculin Biotech, Inc.

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of AtlantaResults demonstrated WP1066 induces anti-tumor immune...
15. Dezember 2025 17:45 ET | Quelle: CEA Industries Inc.

CEA Industries (BNC) Reports FY Q2 2026 Earnings Results

Fiscal Q2 2026 (which began on Aug 1, 2025 and ended Oct 31, 2025) included a $500M private placement, fueling BNC’s digital assets treasury transformation.World’s Largest BNB Treasury with over...
15. Dezember 2025 10:00 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer

AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key Foundation, today announced the publication of a...
15. Dezember 2025 08:30 ET | Quelle: Sagtec Global Limited

Sagtec Global CEO Declares “Pivotal Inflection Point” in Year-End Letter, Citing AI Partnerships and Multi-Million Dollar Contracts as Launchpad for 2026

KUALA LUMPUR, Malaysia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT), a leading provider of AI-driven technology solutions across Southeast Asia, today released a year-end...
12. Dezember 2025 09:25 ET | Quelle: MacKenzie Capital Management, LP

MacKenzie Realty Capital Announces Strategic Review of Multi-family Portfolio

ORINDA, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) announced that it has initiated a strategic review of its multi-family...
12. Dezember 2025 01:30 ET | Quelle: WENDEL

WENDEL: Wendel Investor Day

Wendel's transformation: two powerful value creation engines expected to generate more than €7 billion in cash flow by end 2030 and to return at least €1.6 billion to shareholders Cancellation of...
11. Dezember 2025 18:18 ET | Quelle: Athabasca Oil Corporation

Athabasca Oil Announces its 2026 Budget Focused on Production and Cash Flow Per Share Growth

CALGARY, Alberta, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to announce its 2026 budget with capital projects driving...
10. Dezember 2025 09:55 ET | Quelle: Nova X Foundation

NOX Token to List on LBank Global Exchange

London, United Kingdom, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Nova X, the world’s first user-owned, data-backed super platform, announces the upcoming listing of its ecosystem token, NOX, on LBank, a...
10. Dezember 2025 02:30 ET | Quelle: Bioxodes

Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate

Newton Biocapital enters as new investor, strong participation of existing investorsPivotal Phase 2b trial initiation in 2027 of BIOX-101 to treat intracerebral hemorrhage BIOX-101 may be...

Vorherige Seite

Nächste Seite